Paul Capital provides creative liquidity solutions for direct investments.
Business Model:
Revenue: $1.1M
Employees: 2-10
Address: 50 California St
City: San Francisco
State: CA
Zip: 94111
Country: US
Paul Capital was formed in 1991 as a pioneer in the secondary market, providing creative liquidity solutions to investors in private equity limited partnerships and portfolios of direct investments. In 1999, Paul Capital added its Healthcare Platform to invest in royalty and revenue interests in life science products. Today, Paul Capital sees the world from the vantage point of an experienced investor with unique insight and the ability to build compelling solutions for institutional investors. The team has grown to nearly 100 employees, with offices in Hong Kong, London, New York, Paris, San Francisco and São Paulo, managing a total of more than $6 billion across its distinct investment platforms.
Contact Phone:
+14152834300
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
6/2005 | Verus Pharmaceuticals | Series A | 0 |
7/2010 | Tethys BioScience | Venture Round | 0 |
4/2000 | eVentures Group | Venture Round | 0 |
8/2008 | SpePharm | Venture Round | 0 |
1/2010 | Phase III Development | Private Equity Round | 100M |
11/2006 | Acorda Therapeutics | Post-IPO Equity | 10M |
5/2000 | ROXY.com | Private Equity Round | 0 |
2/2011 | Recyclebank | Series C | 0 |
12/2009 | UCB | Post-IPO Equity | 0 |
6/2007 | On-X Life Technologies | Venture Round | 32M |
4/2011 | Carbon Black | Equity | 12.5M |
4/2011 | Carbon Black | Venture Round | 0 |
2/2011 | Recyclebank | Series C | 0 |
7/2010 | Tethys BioScience | Venture Round | 0 |
1/2010 | Phase III Development | Private Equity Round | 0 |
12/2009 | UCB | Post-IPO Equity | 0 |
8/2008 | SpePharm | Venture Round | 0 |
6/2007 | On-X Life Technologies | Venture Round | 0 |
11/2006 | Acorda Therapeutics | Post-IPO Equity | 0 |
6/2005 | Verus Pharmaceuticals | Series A | 0 |
5/2000 | ROXY.com | Private Equity Round | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|